Search

Your search keyword '"Bordessoule, D."' showing total 56 results

Search Constraints

Start Over You searched for: Author "Bordessoule, D." Remove constraint Author: "Bordessoule, D." Database Academic Search Index Remove constraint Database: Academic Search Index
56 results on '"Bordessoule, D."'

Search Results

1. Advance directives from haematology departments: the patient's freedom of choice and communication with families. A qualitative analysis of 35 written documents.

2. Impact de la TEP dans la prise en charge des lymphomes malins hodgkiniens et non hodgkiniens.

3. RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells.

4. Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).

5. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.

8. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.

9. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

10. Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS

14. SOCS3 inhibits TPO-stimulated, but not spontaneous, megakaryocytic growth in primary myelofibrosis.

15. New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition.

16. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura.

17. Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.

18. Detection of Functional Platelet-Activating Factor Receptors on Leukemic B Cells of Chronic Lymphocytic Leukemic Patients.

19. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.

20. Molecular study of an IgG1κ cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.

21. Allogeneic Transplantation for Patients with Advanced Acute Leukemia: a Single Center Retrospective Study of 92 Patients.

22. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.

23. Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).

24. Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.

25. Lymphangite récurrente du membre supérieur d’origine herpétique

26. Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).

27. 98 - Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries.

30. Quels sont les signes clinico-biologiques permettant d’évoquer le diagnostic de lymphome non-Hodgkinien de type T ?

31. 213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES.

Catalog

Books, media, physical & digital resources